Smither John Winsider trades
In SEC Form 4 filings, Smither John W is listed as Director of NewAmsterdam Pharma Co N.V. (NAMS). In the last 90 days, Smither John W sold $40.5K of NewAmsterdam Pharma Co N.V. (NAMS) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| NAMSNewAmsterdam Pharma Co N.V. | Director | 1 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-09
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.